FY2024 EPS Estimates for Integer Boosted by Zacks Research

Integer Holdings Co. (NYSE:ITGR) – Zacks Research raised their FY2024 earnings estimates for shares of Integer in a report issued on Tuesday, January 7th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will earn $5.33 per share for the year, up from their prior estimate of $5.32. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q1 2025 earnings at $1.32 EPS, Q4 2025 earnings at $1.67 EPS, Q2 2026 earnings at $1.55 EPS and Q4 2026 earnings at $1.76 EPS.

ITGR has been the subject of a number of other research reports. Piper Sandler reiterated an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial raised their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Benchmark increased their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Finally, KeyCorp increased their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Integer presently has an average rating of “Moderate Buy” and an average price target of $145.44.

Integer Trading Up 0.5 %

Shares of Integer stock opened at $133.83 on Thursday. The company has a fifty day simple moving average of $135.88 and a 200-day simple moving average of $127.85. Integer has a 12-month low of $94.56 and a 12-month high of $142.76. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of 41.31, a PEG ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the prior year, the business posted $1.27 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis.

Hedge Funds Weigh In On Integer

Hedge funds have recently added to or reduced their stakes in the business. Contravisory Investment Management Inc. grew its holdings in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares in the last quarter. Huntington National Bank grew its holdings in shares of Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 268 shares in the last quarter. Quest Partners LLC grew its holdings in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 332 shares in the last quarter. Versant Capital Management Inc grew its holdings in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Integer by 74.1% during the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after buying an additional 278 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.